9 天
GlobalData on MSNSpinogenix reports top line outcomes from trial of therapy for Fragile X syndromeUS-based biopharmaceutical company Spinogenix has published top line outcomes from a Phase II trial of SPG601 for treating ...
Eating disorders are characterized by a persistent disturbance of eating patterns that leads to poor physical and/or psychological health. The major eating disorders are anorexia nervosa ...
Feb. 18, 2025 — A new psychological therapy has been found to reduce rates of violence and aggression among male offenders with antisocial personality disorder ... Multiple Sclerosis ...
The cerebellum has been repeatedly implicated in gene expression, rodent model and post-mortem studies of autism spectrum disorder (ASD). How cellular and molecular anomalies of the cerebellum relate ...
The roots of borderline personality disorder still aren’t fully understood. As is the case for many mental health conditions, it seems to be caused by complex interactions between one’s ...
Our primary research focuses on neurodevelopmental disorders, such as autism spectrum disorders (ASD) and fragile X syndrome (FXS), as well as neurodegenerative diseases like Parkinson's disease (PD).
Bipolar disorder is a lifelong condition. It is not yet curable, but medication, therapy, and other strategies can help manage the symptoms and reduce its effects on a person’s daily life.
The table below is a review of notable updates that occurred in January 2025 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果